Literature DB >> 17253866

Hypoxia-selective antitumor agents: norsesterterpene peroxides from the marine sponge Diacarnus levii preferentially suppress the growth of tumor cells under hypoxic conditions.

Jingqiu Dai1, Yang Liu, Yu-Dong Zhou, Dale G Nagle.   

Abstract

As part of an ongoing research program to discover natural products that suppress the hypoxia-activated tumor survival pathways, the lipid extract of the Papua New Guinea marine sponge Diacarnus levii was found to suppress hypoxia-induced HIF-1 activation and hypoxic tumor cell survival. Bioassay-guided isolation of D. levii yielded four new norsesterterpene peroxides, diacarnoxides A - D. Diacarnoxide B exhibits a significantly enhanced ability to suppress the growth of tumor cells under hypoxic conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17253866      PMCID: PMC2910712          DOI: 10.1021/np0604883

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  19 in total

1.  Antimalarial, antiviral, and antitoxoplasmosis norsesterterpene peroxide acids from the Red Sea sponge Diacarnus erythraeanus.

Authors:  K A El Sayed; M T Hamann; N E Hashish; W T Shier; M Kelly; A A Khan
Journal:  J Nat Prod       Date:  2001-04       Impact factor: 4.050

Review 2.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.

Authors:  J von Pawel; R von Roemeling; U Gatzemeier; M Boyer; L O Elisson; P Clark; D Talbot; A Rey; T W Butler; V Hirsh; I Olver; B Bergman; J Ayoub; G Richardson; D Dunlop; A Arcenas; R Vescio; J Viallet; J Treat
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

4.  Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome.

Authors:  D M Brizel; R K Dodge; R W Clough; M W Dewhirst
Journal:  Radiother Oncol       Date:  1999-11       Impact factor: 6.280

5.  Cytotoxic cyclic norterpene peroxides from a Red Sea sponge Diacarnus erythraenus.

Authors:  D T Youssef; W Y Yoshida; M Kelly; P J Scheuer
Journal:  J Nat Prod       Date:  2001-10       Impact factor: 4.050

6.  Mycaperoxide H, a new cytotoxic norsesterterpene peroxide from a Thai marine sponge Mycale sp.

Authors:  Preecha Phuwapraisirisan; Shigeki Matsunaga; Nobuhiro Fusetani; Nilnaj Chaitanawisuti; Sirusa Kritsanapuntu; Piamsak Menasveta
Journal:  J Nat Prod       Date:  2003-02       Impact factor: 4.050

Review 7.  Hypoxia inducible factor-1alpha as a cancer drug target.

Authors:  Garth Powis; Lynn Kirkpatrick
Journal:  Mol Cancer Ther       Date:  2004-05       Impact factor: 6.261

8.  Tasnemoxides A-C, new cytotoxic cyclic norsesterterpene peroxides from the Red Sea sponge Diacarnus erythraenus.

Authors:  Diaa T A Youssef
Journal:  J Nat Prod       Date:  2004-01       Impact factor: 4.050

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  Molecular-targeted antitumor agents: the Saururus cernuus dineolignans manassantin B and 4-O-demethylmanassantin B are potent inhibitors of hypoxia-activated HIF-1.

Authors:  Tyler W Hodges; Chowdhury Faiz Hossain; Yong-Pil Kim; Yu-Dong Zhou; Dale G Nagle
Journal:  J Nat Prod       Date:  2004-05       Impact factor: 4.050

View more
  9 in total

1.  Marine Natural Products as Inhibitors of Hypoxic Signaling in Tumors.

Authors:  Dale G Nagle; Yu-Dong Zhou
Journal:  Phytochem Rev       Date:  2009-06       Impact factor: 5.374

Review 2.  Sesterterpenoids with Anticancer Activity.

Authors:  Antonio Evidente; Alexander Kornienko; Florence Lefranc; Alessio Cimmino; Ramesh Dasari; Marco Evidente; Véronique Mathieu; Robert Kiss
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by epimuqubilin A via IKK/IκB/NF-κB pathways in lipopolysaccharide-stimulated RAW 264.7 cells.

Authors:  Eun-Jung Park; Sarot Cheenpracha; Leng Chee Chang; John M Pezzuto
Journal:  Phytochem Lett       Date:  2011-12-01       Impact factor: 1.679

4.  Inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-activated murine macrophage RAW 264.7 cells by the norsesterterpene peroxide, epimuqubilin A.

Authors:  Sarot Cheenpracha; Eun-Jung Park; Bahman Rostama; John M Pezzuto; Leng Chee Chang
Journal:  Mar Drugs       Date:  2010-03-01       Impact factor: 5.118

5.  Latrunculin A and its C-17-O-carbamates inhibit prostate tumor cell invasion and HIF-1 activation in breast tumor cells.

Authors:  Khalid A El Sayed; Mohammad A Khanfar; Hassan M Shallal; A Muralidharan; Bhushan Awate; Diaa T A Youssef; Yang Liu; Yu-Dong Zhou; Dale G Nagle; Girish Shah
Journal:  J Nat Prod       Date:  2008-02-26       Impact factor: 4.050

Review 6.  Targeting cancer with sesterterpenoids: the new potential antitumor drugs.

Authors:  Caiguo Zhang; Yan Liu
Journal:  J Nat Med       Date:  2015-04-19       Impact factor: 2.343

Review 7.  Synthesis of five- and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products.

Authors:  Alexander O Terent'ev; Dmitry A Borisov; Vera A Vil'; Valery M Dembitsky
Journal:  Beilstein J Org Chem       Date:  2014-01-08       Impact factor: 2.883

8.  Optimization of the Cytotoxic Activity of Three Streptomyces Strains Isolated from Guaviare River Sediments (Colombia, South America).

Authors:  Laura Ramirez-Rodriguez; Boghos Stepanian-Martinez; Maria Morales-Gonzalez; Luis Diaz
Journal:  Biomed Res Int       Date:  2018-07-19       Impact factor: 3.411

Review 9.  Marine Terpenic Endoperoxides.

Authors:  Irene Torres-García; Josefa L López-Martínez; Manuel Muñoz-Dorado; Ignacio Rodríguez-García; Miriam Álvarez-Corral
Journal:  Mar Drugs       Date:  2021-11-25       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.